Vascepa and statins are two different types of medications used to treat different conditions. Vascepa is a prescription medication that contains pure eicosapentaenoic acid (EPA), a type of omega-3 fatty acid, and is used to lower triglyceride levels in adults with severe hypertriglyceridemia. On the other hand, statins are a class of drugs used to lower cholesterol levels in the blood and reduce the risk of heart disease.

According to the sources provided, there is no direct comparison between Vascepa and statins in terms of effectiveness. Vascepa has been shown to significantly reduce triglyceride levels in patients with severe hypertriglyceridemia, while statins have been shown to lower cholesterol levels and reduce the risk of heart disease in patients with high cholesterol levels.

However, a recent study published in the American Journal of Managed Care [3] found that Vascepa may provide additional benefits when added to statin therapy in patients with high cardiovascular risk. The study found that patients who took Vascepa in addition to their statin therapy had a significantly lower risk of cardiovascular events, such as heart attack and stroke, compared to those who only took statins.

In summary, Vascepa and statins are two different medications used to treat different conditions. While Vascepa has been shown to effectively lower triglyceride levels in patients with severe hypertriglyceridemia, statins are used to lower cholesterol levels and reduce the risk of heart disease. While there is no direct comparison between the two medications, recent studies suggest that Vascepa may provide additional benefits when added to statin therapy in patients with high cardiovascular risk.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/VASCEPA
[2] https://www.rxlist.com/vascepa_vs_lipitor/drugs-condition.htm
[3] https://www.ajmc.com/view/patients-take-different-statins-but-vascepa-benefits-are-the-same